home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

PureTech Health plc - American Depositary Shares (NQ:PRTC)

17.42 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PureTech Health plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 30, 2021

Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of...

Via Benzinga

Earnings Scheduled For August 24, 2021 ↗

August 24, 2021

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is likely to report earnings for its second quarter. • Genetron Holdings (NASDAQ:GTH) is...

Via Benzinga

PureTech Health plc – Half-Year Report

August 24, 2021

From PureTech Health plc

Via Business Wire

PureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021

August 23, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments

August 17, 2021

From PureTech Health plc

Via Business Wire

PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer

August 13, 2021

From PureTech Health plc

Via Business Wire

Imbrium Therapeutics To Develop PureTech's Non-Opioid Candidate For Chronic Bladder Condition ↗

August 11, 2021

Imbrium Therapeutics has exercised a license option to develop PureTech Health plc's (NASDAQ: PRTC) LYT-503/IMB-150 (formerly designated as ALV-107...

Via Benzinga

PureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain Syndrome

August 11, 2021

From PureTech Health plc

Via Business Wire

PureTech: Notice of Half-Yearly Results

August 03, 2021

From PureTech Health plc

Via Business Wire

The Week In SPAC News - Sunday, July 25 ↗

July 25, 2021

In SPAC news this week, BBQGuys, PropertyGuru, and Cvent announced merger deals, while Vice Media's plan to go public via a SPAC merger has reportedly stalled.

Via Talk Markets

PureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children With ADHD

July 22, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D Financing

July 21, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.

July 19, 2021

From PureTech Health plc

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 15, 2021

Gainers Nkarta (NASDAQ:NKTX) shares moved upwards by 8.03% to $30.0 during Thursday's regular session. The current volume of 180.7K shares is 71.9% of Nkarta's...

Via Benzinga

PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)

July 09, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Sonde Health Announces Collaboration with Qualcomm Technologies for Use of Vocal Biomarker Technology on Qualcomm Snapdragon Mobile Platforms

July 08, 2021

From PureTech Health plc

Via Business Wire

PureTech Health To Test LYT-200 / Tislelizumab Combo In Difficult To Treat Cancer ↗

July 07, 2021

PureTech Health plc (NASDAQ: PRTC) has announced a clinical trial and supply agreement with an affiliate of BeiGene Ltd (NASDAQ: BGNE). The partnership...

Via Benzinga

PureTech Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors

July 07, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Vedanta Biosciences Announces New Data from Phase 1 Study of VE202 for the Treatment of Inflammatory Bowel Disease

June 30, 2021

From PureTech Health plc

Via Business Wire

Vedanta Biosciences Presents New Data from Phase 1 Study of VE202, Its Rationally-Defined Consortium for the Treatment of Inflammatory Bowel Disease, at the International Human Microbiome Consortium Congress 2021 (IHMC)

June 29, 2021

From Vedanta Biosciences

Via Business Wire

PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers

June 23, 2021

From PureTech Health plc

Via Business Wire

PureTech Adds Inflammatory Disease Candidates To Pipeline With Alivio Buyout ↗

June 16, 2021

Four years after launching Alivio Therapeutics, PureTech Health plc (NASDAQ: PRTC) is bringing the hydrogel player back into the fold by acquiring the...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 16, 2021

Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 72.49% to $17.34 during Wednesday's regular session. As of 12:31 EST, Orphazyme's stock is trading at a...

Via Benzinga

PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics

June 16, 2021

From PureTech Health plc

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 03, 2021

Gainers Kindred Biosciences (NASDAQ:KIN) shares increased by 24.08% to $6.75 during Thursday's regular session. Kindred Biosciences's stock is trading at a volume...

Via Benzinga

Results of Annual General Meeting

May 27, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical Endocrinology (AACE) 2021 Annual Virtual Meeting

May 27, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics

May 26, 2021

From PureTech Health plc

Via Business Wire

PureTech to Present at the Jefferies Virtual Healthcare Conference

May 25, 2021

From PureTech Health plc

Via Business Wire

PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders

May 12, 2021

From PureTech Health plc

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com